Table 1

Patients: clinical and laboratory characteristics

Patient No
1234567891011
Clinical features:
 Onset age (y)2363183642425456555861
 SexFFFMFFFFFFF
 Proximal weakness+++++++++++++++
 Muscle pain+++++++++++
 Dyspnoea and cough+++
 Arthritis+++++++
 Skin rash+++
 Mechanic's hands+++
 Raynaud's phenomenon++
 Steroid response+++++++++
Laboratory data:
 Creatine kinase (IU/l)35 0001000050047002100390150023016001101000
 Packed cell volume3231WNLWNLWNL34423634
 Erythrocyte sedimentation rate (mm/h)132723162560426042
 Antinuclear antibody1:51201:401:80
Muscle pathology:
Inflammation:
   Perimysial+++++++++++++++++++++
   Endomysial++++
   Perivascular+
 Perifascicular muscle fibre
pathology
++++++/Diffuse+++Patchy+++++++++
 Perimysial connective tissue   fragmentation++++++++++++++++
 Acid phosphatase: perimysial    
staining
++++++++++++++++
 Alkaline phosphatase: perimysial   staining++++++++++++++++
 Alkaline phosphatase: small vessel   staining+
Cytochrome oxidase negative muscle fibres+
  • Weakness: ++=Moderate to severe (MRC grade strength⩽ 3 in some muscles); +=Mild (MRC grade strength ⩾4 in all muscles).

  • Other features: +=present; ++=moderately increased; +++=markedly increased; −=negative/absent; ±=equivocal; F=female; M=male.